Upgrade to SI Premium - Free Trial

Amylyx Pharmaceuticals (AMLX) Sets List Price of $12,500 for 28-Day Supply of ALS Drug Relyvrio -- WSJ

September 30, 2022 8:49 AM

Amylyx Pharmaceuticals (NASDAQ: AMLX) Sets List Price of $12,500 for 28-Day Supply of ALS Drug Relyvrio -- WSJ

Categories

Corporate News FDA

Next Articles